About Endospan
Endospan is a company based in Herzliya (Israel) founded in 2009.. Endospan has raised $10 million across 1 funding round from investors including Haisco Pharmaceutical Group, Sequoia Capital and Accelmed Ventures. Endospan offers products and services including NEXUS MULTIBRANCH Aortic Arch Stent Graft System. Endospan operates in a competitive market with competitors including SMT, InspireMD, Vesper Medical, Veryan Medical and Biosensors International, among others.
- Headquarter Herzliya, Israel
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10 M (USD)
in 1 rounds
-
Latest Funding Round
$10 M (USD), Series C
Oct 21, 2015
-
Investors
Haisco Pharmaceutical Group
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Endospan
Endospan offers a comprehensive portfolio of products and services, including NEXUS MULTIBRANCH Aortic Arch Stent Graft System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Custom-made stent graft for endovascular repair of aortic arch aneurysms and stroke risk reduction.
Unlock access to complete
Funding Insights of Endospan
Endospan has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series C round of $10 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $10.0M
-
First Round
First Round
(21 Oct 2015)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2015 | Amount | Series C - Endospan | Valuation | Accelmed Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Endospan
Endospan has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Haisco Pharmaceutical Group, Sequoia Capital and Accelmed Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sequoia Capital is engaged in venture capital investments.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Pharmaceutical products are developed for various therapeutic areas.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Endospan
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Endospan
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Endospan Comparisons
Competitors of Endospan
Endospan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SMT, InspireMD, Vesper Medical, Veryan Medical and Biosensors International, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
SMT is recognized as a developer of cardiovascular medical devices.
|
|
| domain | founded_year | HQ Location |
Proprietary stent systems with bio-stable mesh are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Venous stent system is developed for deep vein disease treatment.
|
|
| domain | founded_year | HQ Location |
Three-dimensional vascular stents for peripheral vascular disease are developed.
|
|
| domain | founded_year | HQ Location |
Products for interventional cardiology and critical care procedures
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Endospan
Frequently Asked Questions about Endospan
When was Endospan founded?
Endospan was founded in 2009 and raised its 1st funding round 6 years after it was founded.
Where is Endospan located?
Endospan is headquartered in Herzliya, Israel. It is registered at Herzliya, Central District, Israel.
Is Endospan a funded company?
Endospan is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series C of $10M, raised on Oct 21, 2015.
What does Endospan do?
Endospan was founded in 2009 in Herzliya, Israel, as a venture capital-backed medical device startup in the cardiovascular sector. An endovascular system for aortic aneurysm repair is being developed at the pre-clinical stage. The Nexus platform is designed to support minimally invasive procedures through real-time aortic insights, incorporating two stent graft systemsHorizon and Nexuswhich remain in clinical development.
Who are the top competitors of Endospan?
Endospan's top competitors include SMT, InspireMD and Vesper Medical.
What products or services does Endospan offer?
Endospan offers NEXUS MULTIBRANCH Aortic Arch Stent Graft System.
Who are Endospan's investors?
Endospan has 3 investors. Key investors include Haisco Pharmaceutical Group, Sequoia Capital, and Accelmed Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.